UTRS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
UTRS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Days Inventory is also known as Days Sales of Inventory (DSI). Minerva Surgical's Average Total Inventories for the three months ended in Sep. 2023 was $18.03 Mil. Minerva Surgical's Cost of Goods Sold for the three months ended in Sep. 2023 was $5.75 Mil. Hence, Minerva Surgical's Days Inventory for the three months ended in Sep. 2023 was 286.31.
The historical rank and industry rank for Minerva Surgical's Days Inventory or its related term are showing as below:
During the past 4 years, Minerva Surgical's highest Days Inventory was 268.47. The lowest was 121.88. And the median was 182.58.
Minerva Surgical's Days Inventory increased from Sep. 2022 (268.07) to Sep. 2023 (286.31). It might indicate that Minerva Surgical's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year. Minerva Surgical's Inventory Turnover for the three months ended in Sep. 2023 was 0.32.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Minerva Surgical's Inventory-to-Revenue for the three months ended in Sep. 2023 was 1.51.
The historical data trend for Minerva Surgical's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Minerva Surgical Annual Data | |||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | |||||
Days Inventory | 121.88 | 146.26 | 218.89 | 257.55 |
Minerva Surgical Quarterly Data | |||||||||||||||
Dec19 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | |
Days Inventory | Get a 7-Day Free Trial | 268.07 | 240.10 | 281.50 | 267.21 | 286.31 |
For the Medical Devices subindustry, Minerva Surgical's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Minerva Surgical's Days Inventory distribution charts can be found below:
* The bar in red indicates where Minerva Surgical's Days Inventory falls into.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Minerva Surgical's Days Inventory for the fiscal year that ended in Dec. 2022 is calculated as
Days Inventory (A: Dec. 2022 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (A: Dec. 2021 ) | + | Total Inventories (A: Dec. 2022 )) | / | count ) | / | Cost of Goods Sold (A: Dec. 2022 ) | * | Days in Period |
= | ( (15.682 | + | 16.85) | / | 2 ) | / | 23.052 | * | 365 |
= | 16.266 | / | 23.052 | * | 365 | ||||
= | 257.55 |
Minerva Surgical's Days Inventory for the quarter that ended in Sep. 2023 is calculated as:
Days Inventory (Q: Sep. 2023 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (Q: Jun. 2023 ) | + | Total Inventories (Q: Sep. 2023 )) | / | count ) | / | Cost of Goods Sold (Q: Sep. 2023 ) | * | Days in Period |
= | ( (17.881 | + | 18.183) | / | 2 ) | / | 5.747 | * | 365 / 4 |
= | 18.032 | / | 5.747 | * | 365 / 4 | ||||
= | 286.31 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Minerva Surgical (OTCPK:UTRS) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Minerva Surgical's Inventory Turnover for the three months ended in Sep. 2023 is calculated as
Inventory Turnover | = | Cost of Goods Sold | / | Average Total Inventories |
= | 5.747 | / | 18.032 | |
= | 0.32 |
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Minerva Surgical's Inventory to Revenue for the three months ended in Sep. 2023 is calculated as
Inventory-to-Revenue | = | Average Total Inventories | / | Revenue |
= | 18.032 | / | 11.965 | |
= | 1.51 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Thank you for viewing the detailed overview of Minerva Surgical's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Daniel Cohen | director | C/O ACCELMED, 848 BRICKELL AVE, #901, MIAMI FL 33131 |
Accelmed Partners Ii L.p. | 10 percent owner | 2875 NE 191ST, SUITE 500, AVENTURA FL 33180 |
New Enterprise Associates 13 Lp | 10 percent owner | 1119 ST PAUL STREET, BALTIMORE MD 21202 |
Uri Geiger | director, 10 percent owner | 221 LATHROP WAY, SUITE I, SACRAMENTO CA 95815 |
Todd Usen | director, officer: Chief Executive Officer | C/O MINERVA SURGICAL, INC., 4255 BURTON DRIVE, SANTA CLARA CA 95054 |
Derrick Sung | director | C/O IRHYTHM TECHNOLOGIES, INC., 650 TOWNSEND STREET, SUITE 380, SAN FRANCISCO CA 94103 |
David M Clapper | director, officer: President and CEO | 3003 TASMAN DRIVE, SANTA CLARA CA 95054 |
Novo Holdings A/s | 10 percent owner | TUBORG HAVNEVEJ 19, HELLERUP G7 2900 |
Jaffe Ross A Md | director | ONE SANSOME STREET, SUITE 3630, SAN FRANCISCO CA 94104 |
Evgueni V. Skalnyi | officer: VP Medical Affairs | C/O MINERVA SURGICAL, INC., 4225 BURTON DRIVE, SANTA CLARA CA 95054 |
Dominique J. Filloux | officer: COO | C/O MINERVA SURGICAL, INC., 4225 BURTON DRIVE, SANTA CLARA CA 95054 |
Joel R Jung | officer: CFO | 1401 HARBOR BAY PARKWAY, ALAMEDA CA 94502 |
Niquette L. Hunt | director | SOLITON, INC., 5304 ASHBROOK DRIVE, HOUSTON TX 77081 |
Jill Anderson | director | 1600 WEST MERIT PARKWAY, SOUTH JORDAN UT 84095 |
Nea Partners 13, Limited Partnership | 10 percent owner | 1119 ST. PAUL STREET, BALTIMORE MD 21202 |
From GuruFocus
By Value_Insider Value_Insider • 10-26-2022
By GuruFocusNews GuruFocusNews • 01-31-2022
By Tiesvg Tiesvg • 12-28-2022
By GuruFocusNews GuruFocusNews • 04-27-2022
By PurpleRose PurpleRose • 08-03-2022
By GuruFocusNews GuruFocusNews • 05-10-2022
By sperokesalga sperokesalga • 02-09-2023
By GuruFocusNews GuruFocusNews • 07-09-2022
By GuruFocusNews GuruFocusNews • 01-04-2022
By GuruFocusNews GuruFocusNews • 05-30-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.